U.S. Ambulatory Surgery Centers Market to Surpass US$ 84,142.8 Million by 2027 - Coherent Market Insights

News provided by

Mar 05, 2020, 10:02 ET

SEATTLE, March 5, 2020 /PRNewswire/ -- According to Coherent Market Insights, the U.S. ambulatory surgery centers market is estimated to be valued at US$ 54,246.6 million in 2019, and is expected to exhibit a CAGR of 5.6% during the forecast period (2019-2027).

Key Trends and Analysis of the U.S. Ambulatory Surgery Centers Market:

U.S. ambulatory surgery centers market is expected to witness significant growth, owing to benefits offered by the ambulatory surgical centers. For instance, advantages offered by ambulatory surgical centers include higher quality services compared to hospitals surgeries, better safety in surgeries, and cost effective surgical procedures such as urology, dermatology, ophthalmology, neurology, and others. Surgeries performed in ambulatory surgical centers are shorter in duration, offers faster post-surgical recovery, have low wait times for the patients, and hospital acquired infection rate is low as patent stay duration is less.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/3531

Key players in the market are focused on strategic collaborations and partnerships to increase their market presence. For instance, on January 22, 2020, Regent Surgical Health, entered into a partnership with physician partners from the Center for Specialized Surgery and Lee Health. The Center for Specialized Surgery is a state-of-the-art ambulatory surgery center dedicated to orthopedics, with specialties including foot & ankle, sports medicine, total joint replacement, spine surgery, pain management, and hand, wrist, & elbow surgery.

Furthermore, increasing number of surgeries in the ambulatory surgery centers is expected to drive the ambulatory surgical centers market growth over the forecast period. For instance, according to the Becker's Ambulatory Surgical Centre Review, in 2011, 5.3 million orthopedic surgeries were performed in 2011 and this is estimated to rise to 6.6 million by 2020, in the U.S.

Key Market Takeaways:

U.S. ambulatory surgery centers market is expected to exhibit CAGR of 5.6% during the forecast period (2019-2027), owing to increasing preference for preforming cataract and vitreoretinal surgeries in ambulatory surgery centers. For instance, according to the Healthcare Cost and Utilization Project (HCUP) report published in 2014, 99.5% of all type of eye surgeries are performed in ambulatory surgery centers in the U.S.
Moreover, increasing reimbursement policies is also expected to contribute to the U.S. ambulatory surgery centers market growth. For instance, the Centers for Medicare & Medicaid Services' (CMS) final 2019 payment rule, revised the definition of 'surgery,' which resulted in the addition of 12 cardiac catheterization procedures for the Medicare ASCs payable list, specifically for vascular, electrophysiology, and diagnostic cardiac catheterization procedures.

Key players operating in the U.S. Ambulatory Surgery Centers market include—

Tenet Healthcare Corporation, AmSurg Corporation, Surgery Partners, Covenant Surgical Partners Inc., Regent Surgical Health L.L.C., and Getinge Group.

Buy this Report Now (Single User License) @ https://www.coherentmarketinsights.com/insight/buy-now/3531

Market Segmentation:

U.S. Ambulatory Surgery Centers Market, By Product Type:

Single Specialty
Multi-Specialty

U.S. Ambulatory Surgery Centers Market, By Ownership:

Physician-only

Hospital-only
Corporate-only
Physician & Hospital
Hospital & Corporate
Corporate & Physician

U.S. Ambulatory Surgery Centers Market, By Procedure Type:

Orthopedic
Cardiovascular
Pain Management
Ophthalmology
Podiatry
Neurology
Dental
Plastic Surgery
ENT
Others

Didn't find what you were looking for? Here are some similar topics:

U.S. INTRAVENOUS SOLUTION MARKET

Increasing prevalence of diarrhea is expected to drive the U.S. intravenous solutions market growth during the forecast period. For instance, according to University of Texas Health Science Center 2014, around 179 million cases of acute diarrhea occur each year in the U.S. and most of those cases are entirely preventable.

HYPERCALCEMIA TREATMENT MARKET

Hypercalcemia is increased level of calcium in the blood which is caused majorly due to malignancy or hyperparathyroidism. Approximately 20 to 30% of cancer patients suffer from hypercalcemia. Hypercalcemia due to cancer is of four types such as humoral hypercalcemia of malignancy, osteolytic hypercalcemia, secretion of active vitamin D by some lymphomas, and ectopic parathyroid hormone (PTH) secretion which is a rare type.

WEIGHT LOSS AND OBESITY MANAGEMENT MARKET

Increasing incidence of obesity in developed and developing economies of the world is expected to assist growth of the weight loss and obesity management market during the forecast period. For instance, according to the WHO reports published in 2018, around 35.8 million disabilities worldwide are caused due to obesity. Furthermore, increasing research and development, and adoption of strategies such as collaborations and development of novel products by market players to expand their geographical footprint is expected to drive growth of the weight loss and obesity management market.

Contact Us:
Mr. Raj Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

SOURCE Coherent Market Insights